Physician profile
Nicolas J Stratton
NPI 1942346994
$3,088.56
in general payments reported to CMS, 2019-2025
11 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.71 · 2020: $703 · 2021: $1,013 · 2023: $38.50 · 2024: $1,125 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $846 · Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $845.70 |
| Food and Beverage | $461.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $1,716.50 | 2020-2021 | |
| Smith+Nephew, INC. | $1,071.75 | 2019-2024 | Real Intelligence |
| Restor3d, INC. | $113.17 | 2025 | |
| Abbott Laboratories | $41.22 | 2024 | Proclaim |
| Pacira Therapeutics, INC. | $32.98 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.75 | 2023 | Zilretta, Iovera, Exparel |
| Stryker Corporation | $24.25 | 2024 | Variax |
| Sanofi-Aventis U.S. LLC | $19.98 | 2019 | |
| Mindray Ds USA, INC. | $15.56 | 2025 | Te X, Te7 Max |
| Heron Therapeutics, INC. | $14.65 | 2025 | Zynrelef |
| Steelhead Surgical INC | $13.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicolas Stratton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.